Related Experiment Videos
A three step supercritical process to improve the dissolution rate of eflucimibe
Elisabeth Rodier1, Hubert Lochard, Martial Sauceau
1Ecole des Mines d'Albi-Carmaux, LGPSD-UMR CNRS 2392, 81013 Albi, France.
Summary
This study enhances Eflucimibe dissolution using gamma-cyclodextrin via supercritical fluid technology. A novel three-step process significantly improves drug dissolution rates, overcoming poor solubility challenges.
Area of Science:
- Pharmaceutical Science
- Materials Science
- Chemical Engineering
Background:
- Eflucimibe is a poorly soluble active pharmaceutical ingredient.
- Improving drug dissolution is crucial for bioavailability and therapeutic efficacy.
- Cyclodextrins are known excipients for enhancing drug solubility.
Purpose of the Study:
- To improve the dissolution properties of Eflucimibe.
- To associate Eflucimibe with gamma-cyclodextrin.
- To develop a novel supercritical fluid-based process for drug-excipient complexation.
Main Methods:
- A three-step supercritical fluid process involving co-crystallization, maturing, and stripping.
- Utilizing supercritical carbon dioxide as an anti-solvent and for extraction.
- Investigating the role of solvent (dimethylsulfoxide) and water addition.
Main Results:
- Co-crystallization ensures good dispersion of Eflucimibe and gamma-cyclodextrin.
- The maturing step, enhanced by water, intensifies contact between compounds.
- The process significantly improves the drug's dissolution rate, though some drug loss occurs during stripping.
Conclusions:
- Supercritical fluid technology offers a synergistic approach to enhance dissolution of poorly soluble drugs.
- The three-step process effectively creates a drug-excipient complex with improved dissolution characteristics.
- Optimization of the stripping step is needed to minimize drug loss and maximize process efficiency.